BiotechTube
Home/Neumirna/Ina Brünig-Traebert, PhD
IB

Ina Brünig-Traebert, PhD

CDO

Neumirna

Therapeutic Areas

NeurologyEpilepsyParkinson's Disease

Neumirna Pipeline

DrugIndicationPhase
NMT.001Drug-Resistant EpilepsyPhase 1
UndisclosedParkinson's DiseasePreclinical

Leadership Team at Neumirna

ED
Ellen Donnelly, PhD
CEO
PR
Peter Rasmussen
CFO
HK
Henrik Klitgaard, PhD
Scientific Co-Founder, Board Member
View full Neumirna profile